Arete Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $486K | Sell |
|
|||||
|
2024
Q2 | $578K | Sell |
|
|||||
|
2024
Q1 | $743K | Sell |
|
|||||
|
2023
Q4 | $689K | Sell |
|
|||||
|
2023
Q3 | $527K | Buy |
|
|||||
|
2023
Q2 | $602K | Sell |
|
|||||
|
2023
Q1 | $498K | Buy |
|
|||||
|
2022
Q4 | $230M | Sell |
|
|||||
|
2022
Q3 | $511K | Buy |
|
|||||
|
2022
Q2 | $405K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $277K | Buy |
|
|||||
|
2021
Q2 | $303K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $250K | Buy |
|